Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tsai-Rong Chung"'
Autor:
Yi-Ying Wu, Tzu-Chuan Huang, Tsung-Neng Tsai, Jia-Hong Chen, Ming-Shen Dai, Ping-Ying Chang, Ching-Liang Ho, Ren-Hua Ye, Tsai-Rong Chung, Yeu-Chin Chen, Tsu-Yi Chao
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151112 (2016)
Trastuzumab-containing treatment regimens have been shown to improve survival outcomes in HER2-positive breast cancer (BC). It is much easier to infuse a fixed one-vial dose to every patient on a regular schedule in the general clinical setting. The
Externí odkaz:
https://doaj.org/article/a36638a52c0845e2b81ab8981ec9abe7
Autor:
Woei Yau Kao, Jacqueline Whang-Peng, Tsu Yi Chao, Tsai Rong Chung, Hui-Ju Ch’ang, Yu Chen Wu, Ann-Lii Cheng, Jang Yang Chang, Wei Lan Yu, Ko Jiunn Liu
Publikováno v:
Journal of Biomedical Science
Background To better evaluate and improve the efficacy of dendritic cell (DC)-based cancer immunotherapy, we conducted a clinical study of patients with advanced colorectal cancer using carcinoembryonic antigen (CEA)-pulsed DCs mixed with tetanus tox
Autor:
Ping-Ying Chang, Ming-Shen Dai, Tsu Yi Chao, Ren Hua Ye, Yeu-Chin Chen, Tsung Neng Tsai, Jia Hong Chen, Yi-Ying Wu, Ching-Liang Ho, Tzu-Chuan Huang, Tsai Rong Chung
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151112 (2016)
PLoS ONE
PLoS ONE
Objective Trastuzumab-containing treatment regimens have been shown to improve survival outcomes in HER2-positive breast cancer (BC). It is much easier to infuse a fixed one-vial dose to every patient on a regular schedule in the general clinical set
Autor:
Ko-Jiunn Liu, Tsu-Yi Chao, Jang-Yang Chang, Ann-Lii Cheng, ChâAng, Hui-Ju, Woei-Yau Kao, Wu, Yu-Chen, Wei-Lan Yu, Tsai-Rong Chung, Whang-Peng, Jacqueline
The complete inclusion and exclusion criteria of patient selection. (DOC 30Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6b33487b48edb11754b4bfcc574ef0
Autor:
Li-Tzong Chen, Tsang Wu Liu, Her Shyong Shiah, Chew Wen Wu, Anna F.Y. Li, Jacqueline Whang Peng, Chieh Lan, Jacqueline Ming Liu, Kuan Der Lee, Tsai Rong Chung
Publikováno v:
Japanese Journal of Clinical Oncology. 34:727-732
This retrospective study aimed to ascertain the expression of erbB2 in relation to topoisomerase II alpha (T2 alpha) and thymidylate synthase (TS) markers in 30 consecutive metastatic gastric cancer patients with a specimen available for study.All pa
Autor:
Tsai Rong Chung, Li-Tzong Chen, Chang Ming Jan, Jacqueline Ming Liu, Chew Wun Wu, Tsang Wu Liu, Jacqueline Whang-Peng, Her Shyong Shiah, Jang Yang Chang
Publikováno v:
Oncology. 63:239-247
Objectives: To determine the maximum-tolerated dose (MTD) and dose-limiting toxicity (DLT) of both docetaxel and 5-fluorouracil (5-FU) when administered weekly in a regimen of docetaxel, 5-FU/leucovorin and cisplatin (DFLP) for 2 consecutive weeks ev
Autor:
Te-Chih Wei, S.F. Huang, Chung-Pin Li, Jang Yang Chang, Wei-Yao Kao, Chih-Hung Hsu, Yan Shen Shan, H. S. Shiah, Chang-Hsien Lu, Mei-Hua Lee, M.-H. Chen, Yen-Yang Chen, Shiang-Yi Chen, Tsai-Rong Chung, Ying-Chun Shen, Ya-Ling Wu, C.-L. Ho, Hung-Chih Hsu, Pei-Chyi Lin, L.-Y. Bai, Yali Yang, Being-Whey Wang, Ling-Fang Lin, L.-T. Chen, Chien-Lin Teng, C.-J. Yen, Ruey Kuen Hsieh, C.S. Tsai, Chih-Chu Wu, K.-D. Lee, Yung-Hsin Chin, Ping-Ying Chang, Shyh-Jer Lin, Chang Fang Chiu, Jin-Shyr Chen, Wen-Chi Shen, M.S. Yu, Chiun Hsu, Cheng-Chung Wu, Yee Chao, Kun-Ming Rau, H.-H. Tsou, Hui-Ling Wang, Wei-Lan Yu, Li-Ju Lu, Nai-Jung Chiang, I.C. Chang, Tsang-En Wang
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 26(5)
Addition of cetuximab showed trend, but not significantly, to improve the therapeutic effects of gemcitabine and oxaliplatin combination for advanced biliary tract cancer in current randomized phase II trial. The trend of improvement did not correlat
Autor:
Ko-Jiunn Liu, Tsu-Yi Chao, Jang-Yang Chang, Ann-Lii Cheng, Hui-Ju Ch'ang, Woei-Yau Kao, Yu-Chen Wu, Wei-Lan Yu, Tsai-Rong Chung, Whang-Peng, Jacqueline
Publikováno v:
Journal of Biomedical Science; 8/24/2016, Vol. 23, p1-11, 11p, 2 Graphs